Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy

被引：0
|
作者：
Son, C. [1 ]
Moey, M. [2 ]
Naqash, A. [3 ]
Walker, P. [4 ]
Peach, M. S. [5 ]
Ju, A. W. [5 ]
机构：
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Dept Cardiovasc Sci, Brody Sch Med, Greenville, NC 27858 USA
[3] East Carolina Univ, Brody Sch Med, Dept Hematol Oncol, Greenville, NC 27858 USA
[4] NCI, Affiliat Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[5] East Carolina Univ, Brody Sch Med, Dept Radiat Oncol, Greenville, NC 27858 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2467
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [31] Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune-Checkpoint Inhibitors for Cancer Treatment
    Patel, Nisha Subhash
    Oury, Anais
    Daniels, Gregory A.
    Bazhenova, Lyudmila
    Patel, Sandip Pravin
    ONCOLOGIST, 2018, 23 (10): : 1236 - 1241
  • [32] Cancer-related fatigue among patients with advanced cancer receiving immune-checkpoint inhibitors: a prospective study
    Yennurajalingam, Sriram
    Thomas, Lisa
    Stanton, Penny A.
    Lu, Zhanni
    de Moraes, Aline Rozman
    Bruera, Eduardo
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [33] The safety and efficacy of immune-checkpoint inhibitor therapy in HIV infected cancer patients.
    Myint, Phyo Thazin
    Ali, Faisal S.
    Verghese, Dhiran
    Alrifai, Taha
    Thet, Aye Mon
    Kozma, Kelley Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Immune-Checkpoint Blockade Therapy in Lymphoma
    Kuzume, Ayumi
    Chi, SungGi
    Yamauchi, Nobuhiko
    Minami, Yosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 15
  • [35] Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
    Roch, Benoit
    Coffy, Amandine
    Jean-Baptiste, Sandy
    Palaysi, Estelle
    Daures, Jean-Pierre
    Pujol, Jean-Louis
    Bommart, Sebastien
    LUNG CANCER, 2020, 143 : 19 - 26
  • [36] The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Zhou, Fei
    Qiao, Meng
    Zhou, Caicun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (02) : 279 - 293
  • [37] The incidence and risk of cardiovascular events among gastroesophageal cancer patients receiving immune-checkpoint inhibitors.
    Ibis, Betul
    Cakir Colak, Sena
    Banga, Akshat
    Song, Junmin
    Chi, Kuan-Yu
    Chang, Yu
    Chiang, Cho Han
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 374 - 374
  • [38] Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors
    Castello, Angelo
    Rossi, Sabrina
    Toschi, Luca
    Lopci, Egesta
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] Neoadjuvant immune-checkpoint inhibitors in lung cancer- a primer for radiologists
    Kifjak, Daria
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Milos, Ruxandra-Iulia
    Heidinger, Benedikt H.
    Prayer, Florian
    Rohrich, Sebastian
    Watzenboeck, Martin L.
    Oberndorfer, Felicitas
    Klikovits, Thomas
    Aigner, Clemens
    Sinn, Katharina
    Hoda, Mir Alireza
    Hoetzenecker, Konrad
    Haug, Alexander R.
    Prosch, Helmut
    Beer, Lucian
    EUROPEAN JOURNAL OF RADIOLOGY, 2023, 161
  • [40] The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Fei Zhou
    Meng Qiao
    Caicun Zhou
    Cellular & Molecular Immunology, 2021, 18 : 279 - 293
12345